Download PDF
Journal of Pediatric Neuroradiology 2016; 05(02): 049-053
DOI: 10.1055/s-0036-1592352
Review Article
Georg Thieme Verlag KG Stuttgart • New York

Common Pediatric Central Nervous System Tumors: Histology and Molecular Biology

Anna C. Goussia
1   Department of Pathology, School of Medicine, University of Ioannina, Ioannina, Greece
› Author Affiliations
Further Information

Publication History

06 April 2016

25 July 2016

Publication Date:
14 September 2016 (online)

    Permissions and Reprints

Abstract

Central nervous system tumors represent the most common solid tumors of childhood. The heterogeneous group of gliomas comprises the majority of pediatric tumors while embryonal neoplasms represent the second most frequent group of tumors. Histopathological diagnosis according to World Health Organization is of great importance for defining prognosis and choosing the appropriate treatment. Recently, attempts have been made to correlate specific genomic alterations to clinical outcome. Adding molecular information to classic histology seems to improve diagnostic accuracy and risk stratification of patients.

Keywords

gliomas - medulloblastoma - pediatric - histology - molecular biology
 

  • References

  • 1 Ostrom QT, Gittleman H, Liao P , et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-oncol 2014; 16 (Suppl. 04) iv1-iv63
    PubMedGoogle Scholar
  • 2 Louis DN, Ohgaki H, Wiestler OD, , et al. WHO Classification of Tumours of the Central Nervous System (Revised 4th edition). Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. , eds. Lyon, France: IARC; 2016
    Google Scholar
  • 3 Rodriguez FJ, Perry A, Gutmann DH , et al. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 2008; 67 (3) 240-249
    CrossrefPubMedGoogle Scholar
  • 4 Kurwale NS, Suri V, Suri A , et al. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?. J Clin Neurosci 2011; 18 (4) 472-477
    CrossrefPubMedGoogle Scholar
  • 5 Jones DT, Kocialkowski S, Liu L , et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008; 68 (21) 8673-8677
    CrossrefPubMedGoogle Scholar
  • 6 Belirgen M, Berrak SG, Ozdag H, Bozkurt SU, Eksioglu-Demiralp E, Ozek MM. Biologic tumor behavior in pilocytic astrocytomas. Childs Nerv Syst 2012; 28 (3) 375-389
    CrossrefPubMedGoogle Scholar
  • 7 Lambert SR, Witt H, Hovestadt V , et al. Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma. Acta Neuropathol 2013; 126 (2) 291-301
    CrossrefPubMedGoogle Scholar
  • 8 Bonfield CM, Steinbok P. Pediatric cerebellar astrocytoma: a review. Childs Nerv Syst 2015; 31 (10) 1677-1685
    CrossrefPubMedGoogle Scholar
  • 9 Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64 (6) 479-489
    Google Scholar
  • 10 Tsugu H, Oshiro S, Yanai F , et al. Management of pilomyxoid astrocytomas: our experience. Anticancer Res 2009; 29 (3) 919-926
    PubMedGoogle Scholar
  • 11 Goussia AC, Agnantis NJ, Rao JS, Kyritsis AP. Cytogenetic and molecular abnormalities in astrocytic gliomas (Review). Oncol Rep 2000; 7 (2) 401-412
    PubMedGoogle Scholar
  • 12 Goussia AC, Polyzoidis K, Bai M , et al. Molecular abnormalities in gliomas. In: Drevelegas A, ed. Imaging of Brain Tumors with Histological Correlations. 2nd ed. Berlin, Heidelberg: Springer-Verlag; 2011
    CrossrefGoogle Scholar
  • 13 Zhang J, Wu G, Miller CP , et al; St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 2013; 45 (6) 602-612
    CrossrefPubMedGoogle Scholar
  • 14 Sturm D, Bender S, Jones DT , et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 2014; 14 (2) 92-107
    CrossrefPubMedGoogle Scholar
  • 15 Goussia AC, Kyritsis AP, Mitlianga P, Bruner JM. Genetic abnormalities in oligodendroglial and ependymal tumours. J Neurol 2001; 248 (12) 1030-1035
    CrossrefPubMedGoogle Scholar
  • 16 Rousseau E, Ruchoux MM, Scaravilli F , et al. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours. Neuropathol Appl Neurobiol 2003; 29 (6) 574-583
    CrossrefPubMedGoogle Scholar
  • 17 Kilday J-P, Rahman R, Dyer S , et al. Pediatric ependymoma: biological perspectives. Mol Cancer Res 2009; 7 (6) 765-786
    CrossrefPubMedGoogle Scholar
  • 18 Rousseau A, Idbaih A, Ducray F , et al. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. J Neurooncol 2010; 97 (3) 353-364
    CrossrefPubMedGoogle Scholar
  • 19 Kalamarides M, Acosta MT, Babovic-Vuksanovic D , et al. Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. Acta Neuropathol 2012; 123 (3) 369-380
    CrossrefPubMedGoogle Scholar
  • 20 Gatta G, Botta L, Rossi S , et al; EUROCARE Working Group. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5—a population-based study. Lancet Oncol 2014; 15 (1) 35-47
    CrossrefPubMedGoogle Scholar
  • 21 Goussia AC, Bruner JM, Kyritsis AP, Agnantis NJ, Fuller GN. Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system. Anticancer Res 2000; 20 (1A) 65-73
    PubMedGoogle Scholar
  • 22 Pan E, Pellarin M, Holmes E , et al. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients. Clin Cancer Res 2005; 11 (13) 4733-4740
    CrossrefPubMedGoogle Scholar
  • 23 Onvani S, Etame AB, Smith CA, Rutka JT. Genetics of medulloblastoma: clues for novel therapies. Expert Rev Neurother 2010; 10 (5) 811-823
    CrossrefPubMedGoogle Scholar
  • 24 Northcott PA, Korshunov A, Witt H , et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29 (11) 1408-1414
    CrossrefPubMedGoogle Scholar
  • 25 Kool M, Korshunov A, Remke M , et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 2012; 123 (4) 473-484
    CrossrefPubMedGoogle Scholar
  • 26 Northcott PA, Jones DT, Kool M , et al. Medulloblastomics: the end of the beginning. Nat Rev Cancer 2012; 12 (12) 818-834
    CrossrefPubMedGoogle Scholar
  • 27 Northcott PA, Dubuc AM, Pfister S, Taylor MD. Molecular subgroups of medulloblastoma. Expert Rev Neurother 2012; 12 (7) 871-884
    CrossrefPubMedGoogle Scholar
  • 28 Remke M, Ramaswamy V, Taylor MD. Medulloblastoma molecular dissection: the way toward targeted therapy. Curr Opin Oncol 2013; 25 (6) 674-681
    CrossrefPubMedGoogle Scholar
  • 29 Shih DJH, Northcott PA, Remke M , et al. Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol 2014; 32 (9) 886-896
    CrossrefPubMedGoogle Scholar
  • 30 Gottardo NG, Hansford JR, McGlade JP , et al. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol 2014; 127 (2) 189-201
    CrossrefPubMedGoogle Scholar
  • 31 Rusert JM, Wu X, Eberhart CG, Taylor MD, Wechsler-Reya RJ. SnapShot: Medulloblastoma. Cancer Cell 2014; 26 (6) 940-940.e1
    CrossrefPubMedGoogle Scholar
  • 32 Ramaswamy V, Remke M, Bouffet E , et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 2016; 131 (6) 821-831
    CrossrefPubMedGoogle Scholar
  • 33 Coluccia D, Figuereido C, Isik S, Smith C, Rutka JT. Medulloblastoma: Tumor biology and relevance to treatment and prognosis paradigm. Curr Neurol Neurosci Rep 2016; 16 (5) 43
    CrossrefPubMedGoogle Scholar
  • 34 Martinez-Barbera JP. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol 2015; 41 (6) 721-732
    CrossrefPubMedGoogle Scholar
  • 35 Visser J, Hukin J, Sargent M, Steinbok P, Goddard K, Fryer C. Late mortality in pediatric patients with craniopharyngioma. J Neurooncol 2010; 100 (1) 105-111
    CrossrefPubMedGoogle Scholar